COVID-19 vaccine messaging that focuses on personal benefits is most effective with those who are hesitant
Genes associated with COVID-19 risk identified
14 May 2021Early biomarker warning of heart disease for diabetic patients
14 May 2021COVID-19 vaccine messaging that focuses on personal benefits is most effective with those who are hesitant
Researchers from the University of Oxford, funded by the National Institute for Health (NIHR) Research Oxford Biomedical Research Center (BRC) and the Oxford Health BRC, tested the responses of a representative group of 18,885 UK adults to a variety of COVID-19 vaccine messaging. The results are published today in the journal The Lancet Public Health.
